NCT07549412
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07549412
Title A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Acronym PROCEADE-CRC-03
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Illinois CancerCare PC RECRUITING Peoria Illinois 61615-7822 United States Details
Profound Research LLC at Cancer and Leukemia Center RECRUITING Sterling Heights Michigan 48098 United States Details
Missouri Cancer Associates - 150518964 RECRUITING Columbia Missouri 65201 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology DFW RECRUITING Bedford Texas 75246 United States Details
Texas Oncology- San Antonio RECRUITING San Antonio Texas 78240 United States Details
GenesisCare North Shore (Oncology) RECRUITING St Leonards New South Wales 2065 Australia Details
Icon Cancer Centre Chermside RECRUITING Chermside Queensland 4032 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field